REVOLUTION MEDICINES INC (1RVMD.MI) Fundamental Analysis & Valuation

BIT:1RVMD • US76155X1000

Current stock price

126.15 EUR
+43.15 (+51.99%)
Last:

This 1RVMD.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. 1RVMD.MI Profitability Analysis

1.1 Basic Checks

  • 1RVMD had negative earnings in the past year.
  • In the past year 1RVMD has reported a negative cash flow from operations.
  • In the past 5 years 1RVMD always reported negative net income.
  • 1RVMD had a negative operating cash flow in each of the past 5 years.
1RVMD.MI Yearly Net Income VS EBIT VS OCF VS FCF1RVMD.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M -800M -1B

1.2 Ratios

  • 1RVMD has a Return On Assets (-48.05%) which is comparable to the rest of the industry.
  • 1RVMD's Return On Equity of -69.35% is in line compared to the rest of the industry. 1RVMD outperforms 56.79% of its industry peers.
Industry RankSector Rank
ROA -48.05%
ROE -69.35%
ROIC N/A
ROA(3y)-30.89%
ROA(5y)-29.73%
ROE(3y)-39.91%
ROE(5y)-37.42%
ROIC(3y)N/A
ROIC(5y)N/A
1RVMD.MI Yearly ROA, ROE, ROIC1RVMD.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for 1RVMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1RVMD.MI Yearly Profit, Operating, Gross Margins1RVMD.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. 1RVMD.MI Health Analysis

2.1 Basic Checks

  • 1RVMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for 1RVMD has been increased compared to 1 year ago.
  • 1RVMD has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for 1RVMD is higher compared to a year ago.
1RVMD.MI Yearly Shares Outstanding1RVMD.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
1RVMD.MI Yearly Total Debt VS Total Assets1RVMD.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 21.84 indicates that 1RVMD is not in any danger for bankruptcy at the moment.
  • 1RVMD's Altman-Z score of 21.84 is amongst the best of the industry. 1RVMD outperforms 92.59% of its industry peers.
  • 1RVMD has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • 1RVMD's Debt to Equity ratio of 0.16 is fine compared to the rest of the industry. 1RVMD outperforms 60.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 21.84
ROIC/WACCN/A
WACC9.55%
1RVMD.MI Yearly LT Debt VS Equity VS FCF1RVMD.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B

2.3 Liquidity

  • A Current Ratio of 7.14 indicates that 1RVMD has no problem at all paying its short term obligations.
  • The Current ratio of 1RVMD (7.14) is better than 83.95% of its industry peers.
  • A Quick Ratio of 7.14 indicates that 1RVMD has no problem at all paying its short term obligations.
  • 1RVMD has a Quick ratio of 7.14. This is amongst the best in the industry. 1RVMD outperforms 83.95% of its industry peers.
Industry RankSector Rank
Current Ratio 7.14
Quick Ratio 7.14
1RVMD.MI Yearly Current Assets VS Current Liabilites1RVMD.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. 1RVMD.MI Growth Analysis

3.1 Past

  • 1RVMD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -65.55%.
EPS 1Y (TTM)-65.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.07%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • 1RVMD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.03% yearly.
  • The Revenue is expected to grow by 308.02% on average over the next years. This is a very strong growth
EPS Next Y-33.36%
EPS Next 2Y-7.52%
EPS Next 3Y5.14%
EPS Next 5Y27.03%
Revenue Next Year1118.77%
Revenue Next 2Y778.35%
Revenue Next 3Y490.45%
Revenue Next 5Y308.02%

3.3 Evolution

1RVMD.MI Yearly Revenue VS Estimates1RVMD.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B 8B 10B
1RVMD.MI Yearly EPS VS Estimates1RVMD.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 10 20

More info and screens

Find the best growth stocksShow best growing peers

0

4. 1RVMD.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for 1RVMD. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 1RVMD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1RVMD.MI Price Earnings VS Forward Price Earnings1RVMD.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1RVMD.MI Per share data1RVMD.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.52%
EPS Next 3Y5.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1RVMD.MI Dividend Analysis

5.1 Amount

  • 1RVMD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1RVMD.MI Fundamentals: All Metrics, Ratios and Statistics

REVOLUTION MEDICINES INC

BIT:1RVMD (4/15/2026, 7:00:00 PM)

126.15

+43.15 (+51.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength55.9
Industry Growth13.66
Earnings (Last)02-25
Earnings (Next)05-11
Inst Owners100.23%
Inst Owner ChangeN/A
Ins Owners1.92%
Ins Owner ChangeN/A
Market Cap25.00B
Revenue(TTM)N/A
Net Income(TTM)-1.13B
Analysts87.41
Price Target115.11 (-8.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.3%
Min EPS beat(2)-15.36%
Max EPS beat(2)-11.24%
EPS beat(4)0
Avg EPS beat(4)-10.23%
Min EPS beat(4)-15.36%
Max EPS beat(4)-1.54%
EPS beat(8)1
Avg EPS beat(8)-6.23%
EPS beat(12)3
Avg EPS beat(12)-5.8%
EPS beat(16)6
Avg EPS beat(16)-2.46%
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)14.38%
PT rev (3m)49.8%
EPS NQ rev (1m)-10.53%
EPS NQ rev (3m)-10.53%
EPS NY rev (1m)-16.51%
EPS NY rev (3m)-20.34%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)52.9%
Revenue NY rev (3m)54.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 17.95
P/tB 18.76
EV/EBITDA N/A
EPS(TTM)-5.05
EYN/A
EPS(NY)-6.73
Fwd EYN/A
FCF(TTM)-3.94
FCFYN/A
OCF(TTM)-3.87
OCFYN/A
SpS0
BVpS7.03
TBVpS6.73
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -48.05%
ROE -69.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-30.89%
ROA(5y)-29.73%
ROE(3y)-39.91%
ROE(5y)-37.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 184.86%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.14
Quick Ratio 7.14
Altman-Z 21.84
F-Score3
WACC9.55%
ROIC/WACCN/A
Cap/Depr(3y)148.83%
Cap/Depr(5y)163.7%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.07%
EPS Next Y-33.36%
EPS Next 2Y-7.52%
EPS Next 3Y5.14%
EPS Next 5Y27.03%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year1118.77%
Revenue Next 2Y778.35%
Revenue Next 3Y490.45%
Revenue Next 5Y308.02%
EBIT growth 1Y-71.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-40.29%
EBIT Next 3Y2.44%
EBIT Next 5Y27.39%
FCF growth 1Y-60.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.05%
OCF growth 3YN/A
OCF growth 5YN/A

REVOLUTION MEDICINES INC / 1RVMD.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of REVOLUTION MEDICINES INC (1RVMD.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to 1RVMD.MI.


What is the valuation status for 1RVMD stock?

ChartMill assigns a valuation rating of 0 / 10 to REVOLUTION MEDICINES INC (1RVMD.MI). This can be considered as Overvalued.


What is the profitability of 1RVMD stock?

REVOLUTION MEDICINES INC (1RVMD.MI) has a profitability rating of 1 / 10.


How financially healthy is REVOLUTION MEDICINES INC?

The financial health rating of REVOLUTION MEDICINES INC (1RVMD.MI) is 6 / 10.